Dosing Options Provide Benefits for Cholesterol Control with Praluent

Video

Doctors prescribing Praluent for their patients have two dosing options to choose from. Studies on the treatment option have shown that the safety profile for both are good for patients.

Doctors prescribing Praluent for their patients have two dosing options to choose from. Studies on the treatment option have shown that the safety profile for both are good for patients.

For many patients, the 75mg dose is enough to lower a patient's LDL levels into the safer range of the spectrum. For those who need additional help, providers can prescribe 150mg — which has shown to reduce LDL closer to 60%. Jay Edelberg, MD, PhD, and Sheldon Koenig, from Sanofi, discussed the benefits of the two doses during the American Heart Association's Scientific Sessions in New Orleans, LA.

PCSK9 inhibitors have been on the market for less than two years and, because of that, Koenig said there is more work that needs to be done to raise awareness of the benefits of the agents with the public with the help of their providers and other sources.

Recent Videos
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
© 2024 MJH Life Sciences

All rights reserved.